Výsledky vyhledávání - "Reck dos Santos, P."

Akademický článek

Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation

Autor: J. Asher Jenkins, Ricardo Verdiner, Ashraf Omar, Juan Maria Farina, Renita Wilson, Jonathan D’Cunha, Pedro Augusto Reck Dos Santos

Publikováno v: Frontiers in Immunology, Vol 15 (2024)

Primary Graft Dysfunction (PGD) is a major cause of both short-term and long-term morbidity and mortality following lung transplantation. Various donor, recipient, and technical risk factors have been previously identified as being associated with th

Externí odkaz: https://doaj.org/article/aba71efbfda347afb79058a4d4c54698

Zobrazit plný text záznamu

Akademický článek

Clinical outcomes of stage-IV non–small-cell lung cancer in young patients and the impact of tumor markers

Autor: Pedro Augusto Reck dos Santos, Yalun Li, Vinicius Ernani, Jonathan D'Cunha, Marie-Christine Aubry, Ping Yang

Publikováno v: Cancer Treatment and Research Communications, Vol 36, Iss , Pp 100723- (2023)

Introduction: Non-Small Cell Lung Cancer (NSCLC) diagnosed at a younger age have patterns of care, responses to treatment, and outcomes not entirely clear. A particular feature includes more advanced stages at diagnosis. Our objective was to characte

Externí odkaz: https://doaj.org/article/f8c2d118af5541b4b12e7ff68e7e087a

Zobrazit plný text záznamu

Akademický článek

Solid phase microextraction chemical biopsy tool for monitoring of doxorubicin residue during in vivo lung chemo-perfusion

Autor: Barbara Bojko, Nikita Looby, Mariola Olkowicz, Anna Roszkowska, Bogumiła Kupcewicz, Pedro Reck dos Santos, Khaled Ramadan, Shaf Keshavjee, Thomas K. Waddell, German Gómez-Ríos, Marcos Tascon, Krzysztof Goryński, Marcelo Cypel, Janusz Pawliszyn

Publikováno v: Journal of Pharmaceutical Analysis, Vol 11, Iss 1, Pp 37-47 (2021)

Development of a novel in vivo lung perfusion (IVLP) procedure allows localized delivery of high-dose doxorubicin (DOX) for targeting residual micrometastatic disease in the lungs. However, DOX delivery via IVLP requires careful monitoring of drug le

Externí odkaz: https://doaj.org/article/d1fb75d329604835b60477b6d1e8cf4d

Zobrazit plný text záznamu